The India-based company Veeda Clinical Research continued its acquisitive ways by buying International Oncology Network (ION), a clinical research company with 50 clinical trial sites across the US. ION, headquartered in Texas, was part of Amerisource Bergen. The purchase price was not disclosed. ION will become part of the cancer subsidiary of Veeda, known as Veeda Oncology. Veeda has been active recently in acquisitions. More details...

Stock Symbols: (NYSE: LLY) (NYSE: DNA) (NYSE: SNY) (NYSE: BMY) (NYSE: WX)